BLA Exclusivity Would Ease Acquisitions And Improve R&D Focus, Lilly Says
Executive Summary
Lilly has found another reason for follow-on biologics legislation to provide 14 years of data exclusivity for innovators: it will make the vetting process easier in mergers and acquisitions